• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)抑制来自Fas、肿瘤坏死因子(TNF)和肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体的凋亡信号。

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.

作者信息

Tran S E, Holmstrom T H, Ahonen M, Kahari V M, Eriksson J E

机构信息

Turku Centre for Biotechnology, POB 123, FIN-20521, University of Turku, Turku, Finland.

出版信息

J Biol Chem. 2001 May 11;276(19):16484-90. doi: 10.1074/jbc.M010384200. Epub 2001 Jan 25.

DOI:10.1074/jbc.M010384200
PMID:11278665
Abstract

The tumor necrosis factor (TNF), Fas, and TNF-related apoptosis-inducing ligand (TRAIL) receptors (R) are highly specific physiological mediators of apoptotic signaling. We observed earlier that a number of FasR-insensitive cell lines could redirect the proapoptotic signal to an anti-apoptotic ERK1/2 signal resulting in inhibition of caspase activation. Here we determine that similar mechanisms are operational in regulating the apoptotic signaling of other death receptors. Activation of the FasR, TNF-R1, and TRAIL-R, respectively, rapidly induced subsequent ERK1/2 activation, an event independent from caspase activity. Whereas inhibition of the death receptor-mediated ERK1/2 activation was sufficient to sensitize the cells to apoptotic signaling from FasR and TRAIL-R, cells were still protected from apoptotic TNF-R1 signaling. The latter seemed to be due to the strong activation of the anti-apoptotic factor NF-kappaB, which remained inactive in FasR or TRAIL-R signaling. However, when the cells were sensitized with cycloheximide, which is sufficient to sensitize the cells also to apoptosis by TNF-R1 stimulation, we noticed that adenovirus-mediated expression of constitutively active MKK1 could rescue the cells from apoptosis induced by the respective receptors by preventing caspase-8 activation. Taken together, our results show that ERK1/2 has a dominant protecting effect over apoptotic signaling from the death receptors. This protection, which is independent of newly synthesized proteins, acts in all cases by suppressing activation of the caspase effector machinery.

摘要

肿瘤坏死因子(TNF)、Fas和TNF相关凋亡诱导配体(TRAIL)受体(R)是凋亡信号高度特异性的生理介质。我们之前观察到,一些对FasR不敏感的细胞系可将促凋亡信号重定向为抗凋亡的ERK1/2信号,从而抑制半胱天冬酶激活。在此,我们确定类似机制在调节其他死亡受体的凋亡信号中也起作用。分别激活FasR、TNF-R1和TRAIL-R后,会迅速诱导随后的ERK1/2激活,这一事件独立于半胱天冬酶活性。虽然抑制死亡受体介导的ERK1/2激活足以使细胞对来自FasR和TRAIL-R的凋亡信号敏感,但细胞仍受到保护,免受TNF-R1凋亡信号的影响。后者似乎是由于抗凋亡因子NF-κB的强烈激活,而NF-κB在FasR或TRAIL-R信号中保持无活性。然而,当用环己酰亚胺使细胞敏感化时(环己酰亚胺也足以使细胞对TNF-R1刺激诱导的凋亡敏感),我们注意到腺病毒介导的组成型活性MKK1的表达可通过阻止半胱天冬酶-8激活,使细胞从各自受体诱导的凋亡中获救。综上所述,我们的结果表明,ERK1/2对死亡受体的凋亡信号具有主导性保护作用。这种保护作用独立于新合成的蛋白质,在所有情况下均通过抑制半胱天冬酶效应机制的激活来发挥作用。

相似文献

1
MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)抑制来自Fas、肿瘤坏死因子(TNF)和肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体的凋亡信号。
J Biol Chem. 2001 May 11;276(19):16484-90. doi: 10.1074/jbc.M010384200. Epub 2001 Jan 25.
2
Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.丝裂原活化激酶信号传导的抑制使HeLa细胞对Fas受体介导的凋亡敏感。
Mol Cell Biol. 1999 Sep;19(9):5991-6002. doi: 10.1128/MCB.19.9.5991.
3
Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.活化T细胞中的丝裂原活化蛋白激酶/细胞外信号调节激酶信号传导在线粒体放大环和半胱天冬酶-8的上游消除了肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的细胞凋亡。
J Immunol. 2002 Sep 15;169(6):2851-60. doi: 10.4049/jimmunol.169.6.2851.
4
Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).一种对放线菌酮敏感的因子对死亡受体介导的基因诱导的抑制作用发生在Fas相关死亡结构域蛋白(FADD)水平或其上游。
J Biol Chem. 2000 Aug 11;275(32):24357-66. doi: 10.1074/jbc.M000811200.
5
Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.肿瘤坏死因子相关凋亡诱导配体受体通过不同途径信号传导NF-κB和JNK激活及凋亡。
J Biol Chem. 1999 Oct 22;274(43):30603-10. doi: 10.1074/jbc.274.43.30603.
6
Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.通过抑制Fas相关死亡结构域蛋白(FADD)/半胱天冬酶信号传导对死亡受体细胞毒性的致敏作用。细胞周期进程的要求。
J Biol Chem. 2000 Aug 11;275(32):24670-8. doi: 10.1074/jbc.M003280200.
7
Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.半胱天冬酶抑制剂可诱导CD95刺激的T淋巴细胞从凋亡信号转导转变为促炎信号转导。
Eur J Immunol. 2002 Sep;32(9):2471-80. doi: 10.1002/1521-4141(200209)32:9<2471::AID-IMMU2471>3.0.CO;2-E.
8
Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.蛋白激酶C通过靶向死亡受体信号传导的顶端事件来调节肿瘤坏死因子相关凋亡诱导配体诱导的凋亡。
J Biol Chem. 2003 Nov 7;278(45):44338-47. doi: 10.1074/jbc.M307376200. Epub 2003 Aug 14.
9
Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis.在一氧化氮诱导的心肌细胞凋亡过程中JNK激酶的细胞保护作用
Circ Res. 2001 Feb 16;88(3):305-12. doi: 10.1161/01.res.88.3.305.
10
Inhibition of p38 kinase reveals a TNF-alpha-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line.p38激酶的抑制揭示了人骨髓单核细胞系中一条由肿瘤坏死因子-α介导的、半胱天冬酶依赖性的凋亡死亡途径。
J Immunol. 2001 Jun 1;166(11):6570-7. doi: 10.4049/jimmunol.166.11.6570.

引用本文的文献

1
Reduction of endocytosis and EGFR signaling is associated with the switch from isolated to clustered apoptosis during epithelial tissue remodeling in Drosophila.在果蝇的上皮组织重塑过程中,从孤立凋亡到聚集凋亡的转变与内吞作用和 EGFR 信号的减少有关。
PLoS Biol. 2024 Oct 14;22(10):e3002823. doi: 10.1371/journal.pbio.3002823. eCollection 2024 Oct.
2
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches.细胞因子风暴导致的 COVID-19 甲状腺功能障碍:发病机制和治疗方法的见解。
Drug Des Devel Ther. 2024 Sep 20;18:4215-4240. doi: 10.2147/DDDT.S475005. eCollection 2024.
3
Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.
线粒体靶向药物 LND 和(E)- Akt 抑制剂-IV:诱导内质网应激和 ROS 积累的新型化合物,用于治疗肝细胞癌。
J Transl Med. 2024 Aug 28;22(1):792. doi: 10.1186/s12967-024-05545-5.
4
Navigating the ERK1/2 MAPK Cascade.ERK1/2 MAPK 级联途径的探索。
Biomolecules. 2023 Oct 20;13(10):1555. doi: 10.3390/biom13101555.
5
Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells.核心岩藻糖基化由 FucT-8 酶介导影响 TRAIL 诱导的凋亡和对人 SW480 和 SW620 结肠癌细胞化疗的敏感性。
Int J Mol Sci. 2023 Jul 25;24(15):11879. doi: 10.3390/ijms241511879.
6
Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy.生成NTRK融合间叶性肿瘤的体外模型,作为研究激酶致癌激活和对靶向治疗反应的工具。
Oncogenesis. 2023 Feb 17;12(1):8. doi: 10.1038/s41389-023-00454-6.
7
Caspase 3-specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress-induced apoptosis.Caspase 3 特异性切割 MEK1 抑制 ERK 信号转导并使细胞对应激诱导的细胞凋亡敏感。
FEBS Open Bio. 2023 Apr;13(4):684-700. doi: 10.1002/2211-5463.13574. Epub 2023 Feb 23.
8
Life at the periphery: what makes CHO cells survival talents.边缘生活:CHO 细胞的生存之道。
Appl Microbiol Biotechnol. 2022 Sep;106(18):6157-6167. doi: 10.1007/s00253-022-12123-6. Epub 2022 Aug 30.
9
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis.FAS受体通过ERK-JAG1轴激活调节NOTCH活性,并控制口腔癌的干性能力和肺转移。
Cell Death Discov. 2022 Mar 5;8(1):101. doi: 10.1038/s41420-022-00899-5.
10
Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress.神经元源性孤儿受体1(NOR-1)的过表达可挽救阿霉素诱导应激后死亡的心肌细胞并提高其活力。
Biomedicines. 2021 Sep 16;9(9):1233. doi: 10.3390/biomedicines9091233.